Injection of fibrin sealant including an anesthetic in spinal applications
First Claim
Patent Images
1. A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus, comprising:
- injecting a fibrin sealant into the disc to reduce at least a portion of the at least one defect, wherein the fibrin sealant injected into the disc comprises an anesthetic, fibrinogen and an activating compound, wherein at least a portion of the fibrin forms after injection, with the proviso that a corticosteroid is absent from the fibrin sealant injected into the disc.
8 Assignments
0 Petitions
Accused Products
Abstract
A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus. The method includes injecting a fibrin sealant into the disc to reduce at least a portion of the at least one defect, wherein the fibrin sealant injected into the disc comprises an anesthetic, fibrinogen and an activating compound, wherein at least a portion of the fibrin forms after injection, with the proviso that a corticosteroid is absent from the fibrin sealant injected into the disc.
88 Citations
78 Claims
-
1. A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus, comprising:
- injecting a fibrin sealant into the disc to reduce at least a portion of the at least one defect, wherein the fibrin sealant injected into the disc comprises an anesthetic, fibrinogen and an activating compound, wherein at least a portion of the fibrin forms after injection, with the proviso that a corticosteroid is absent from the fibrin sealant injected into the disc.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
25. A method of treating a human back, comprising injecting a fibrin sealant into a disc to seal at least one defect of an annulus fibrosus, wherein the fibrin sealant comprises an anesthetic, fibrinogen and thrombin, wherein the fibrinogen and thrombin forms at least a portion of the fibrin after injection, and wherein the fibrin sealant does not include a corticosteroid.
-
26-47. -47. (canceled)
-
48. A method of treating a human back, comprising providing a mixture of anesthetic, fibrinogen and thrombin within a human disc to treat at least one defect of an annulus fibrosus, and wherein a corticosteroid is absent from the mixture.
-
49-69. -69. (canceled)
-
70. A kit, comprising:
- an anesthetic, fibrinogen, thrombin, optionally at least one additive, a spinal needle, wherein the kit excludes corticosteroid and wherein the kit excludes a device to provide thermal energy to a disc.
-
71-76. -76. (canceled)
-
77. A process for manufacturing a kit, comprising:
- providing a fibrinogen component, a thrombin component, an anesthetic component, and a spinal needle or a polymeric catheter or both, wherein the kit excludes corticosteroid and wherein the kit excludes a device to provide thermal energy to a disc.
-
78-79. -79. (canceled)
Specification